European Reference Laboratory Network for Human Influenza (ERLI-Net)
The ERLI-Net sub-network of reference laboratories of the European Influenza Surveillance Network carries out virological surveillance of human influenza in the EU/EEA through the EISN timely reporting mechanism and strengthening laboratory capacity for influenza virus detection, antiviral susceptibility testing and typing.
Target 2.1. Provision and regulation of NRL microbiology services
A strong target, for which the majority of the EU/EEA countries show a stable, intermediate to high level of capacity/capability of organisation, regulation, and funding of their NRL infrastructure and delivery core public health functions over the years.
Target 2.2. Reference diagnostic confirmation and pathogen identification
A fairly strong target, the level of reference testing capability/capacity remains intermediate in a majority of the EU/EEA countries with a narrowing inter-country range. The observed dip between 2013 and 2014 is likely due to changes in the indicator scoring method between those surveys.
Target 2.3. Molecular typing for surveillance
A challenging target with low baseline level of capability/capacity in many EU/EEA countries for use of molecular typing for surveillance at national and EU levels, as measured by the selected indicators over the year.
Target 2.4. Antimicrobial drug resistance characterisation and monitoring
A strong target, the capacity/capability of the EU/EEA countries to accurately characterise and monitor antimicrobial resistance determinants for national/EU-wide surveillance increased on average from intermediate to high level from 2013 to 2014.